-
Mashup Score: 0Hepatocellular Carcinoma Surveillance Following Hepatitis C Virus Cure – Gastroenterology & Hepatology - 10 hour(s) ago
Paul Y. Kwo, MD Professor of Medicine Director of Hepatology Division of Gastroenterology and Hepatology Stanford University Medical School Stanford, California G & H What is the current understanding of the effect of hepatitis C virus cure on the risk of hepatocellular carcinoma? PK There have been tremendous advances in the treatment of patients with hepatitis C virus (HCV) infection. More than 95% of patients infected with HCV can now achieve sustained virologic response (SVR), or cure, with short
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Inflammatory Bowel Disease – Gastroenterology & Hepatology - 6 day(s) ago
Christine Boumitri, MD Assistant Professor Feinberg School of Medicine Northwestern Medicine Chicago, Illinois G & H How prevalent are obesity and overweight in patients with inflammatory bowel disease, and how can these conditions affect this patient population? CB With the global increase in obesity and overweight, a similar trend has been seen in patients with inflammatory bowel disease (IBD), a population historically considered to be malnourished. Recent studies have shown that 15% to 40% of patients
Categories: General Medicine News, GastroenterologyTweet-
“Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Inflammatory Bowel Disease” with Christine Boumitri, MD https://t.co/aPyQBjoJw7 @NUFeinbergMed @NorthwesternMed #IBD
-
-
Mashup Score: 0Navigating Chronic Pouchitis: Pathogenesis, Diagnosis, and Management – Gastroenterology & Hepatology - 8 day(s) ago
Robert Hill, MBBS Translational Gastroenterology Unit, University of Oxford, Oxford, United Kingdom Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom Simon Travis, DPhil, FRCP Translational Gastroenterology Unit, Un iversity of Oxford, Oxford, United Kingdom Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom Biomedical Research Centre, University of Oxford, Oxford, United Kingdom Zaid Ardalan, MBChB, PhD, FRACP Alfred Health, Melbourne, Australia
Categories: General Medicine News, GastroenterologyTweet-
“Navigating Chronic Pouchitis: Pathogenesis, Diagnosis, and Management” by Robert Hill, MBBS, Simon Travis, DPhil, FRCP, and Zaid Ardalan, MBChB, PhD, FRACP https://t.co/CHvIlXrhlx @KirOxford @UniofOxford @NDORMS
-
-
Mashup Score: 0Case Study Series: Patient–Provider Communication: The Key to Improving IBS-C Management – Gastroenterology & Hepatology - 10 day(s) ago
Christina Hanson, FNP-C South Denver Gastroenterology Englewood, Colorado KS is a 34-year-old accountant presenting to the clinic as a new consult for long-standing history of abdominal pain and bloating with irregular bowel habits characterized by constipation. She describes her constipation as days between bowel movements as well as straining with harder stools and a frequent sensation of incomplete evacuation. KS describes nearly daily bloating that worsens as the day progresses and has not responded
Categories: General Medicine News, GastroenterologyTweet-
“Patient–Provider Communication: The Key to Improving IBS-C Management” by Christina Hanson, FNP-C https://t.co/yeFLKG34HE #ibsc
-
-
Mashup Score: 1
David J. Cangemi, MD Division of Gastroenterology & Hepatology, R. Christopher Chase, MD Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida Brian E. Lacy, PhD, MD Division of Gastroenterology & Hepatology, Corresponding author: David J. Cangemi, MD Mayo Clinic Division of Gastroenterology & Hepatology 4 500 San Pablo Road Jacksonville, FL 32224 Tel: (904) 953-6970 Fax: (904) 953-6225 E-mail: cangemi.david@mayo.edu Abstract: Nausea and vomiting are common symptoms that frequently lead to
Categories: General Medicine News, GastroenterologyTweet-
“Approach to Meal-Related Nausea and Vomiting” by David J. Cangemi, MD, R. Christopher Chase, MD, and Brian E. Lacy, PhD, MD https://t.co/KdzjGQzFPk @dcangemi @MayoClinic
-
-
Mashup Score: 1Current Issue – Gastroenterology & Hepatology - 16 day(s) ago
Abstract: Tremendous effort has been put forth over the past 2 decades in understanding the pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). Although multiple potential […] Abstract: Barrett esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EAC), a cancer that continues to have a poor 5-year survival rate of 20%. […] G & H What led to the concept of a treat-to-target approach for the management of patients with inflammatory bowel
Categories: General Medicine News, GastroenterologyTweet-
The latest issue of Gastroenterology & Hepatology is now available online https://t.co/GtoiDSlzRi #gastroenterology #hepatology
-
-
Mashup Score: 0Are All Esophageal Ulcers Caused by Gastroesophageal Reflux Disease? – Gastroenterology & Hepatology - 1 month(s) ago
Nayantara Coelho-Prabhu, MD Professor of Medicine Consultant, Division of Gastroenterology and Hepatology Mayo Clinic Rochester, Minnesota G & H What are some important clinical differences between gastroesophageal reflux disease and esophageal ulcers? NC Esophageal ulcers can occur as a result of gastroesophageal reflux disease (GERD), but they can develop from various other causes such as infections, drug-induced injury, and malignancy. Not all GERD causes esophageal ulcers, and not all esophageal
Categories: General Medicine News, GastroenterologyTweet-
“Are All Esophageal Ulcers Caused by Gastroesophageal Reflux Disease?” with Nayantara Coelho-Prabhu, MBBS https://t.co/DeIBvfh7Yr @NayantaraCoelho @MayoClinic #GERD
-
-
Mashup Score: 1The Potential Role of Hyperbaric Oxygen Therapy in Patients With Inflammatory Bowel Disease – Gastroenterology & Hepatology - 1 month(s) ago
Parambir S. Dulai, MD Associate Professor of Medicine Director of GI Clinical Trials and Precision Medicine Division of Gastroenterology and Hepatology Feinberg School of Medicine No rthwestern University Chicago, Illinois G & H Why has hyperbaric oxygen therapy been considered for the treatment of patients with inflammatory bowel disease? PD Inflammatory bowel disease (IBD), which encompasses both Crohn’s disease and ulcerative colitis, is a multifactorial autoimmune disorder of the gastrointestinal (GI)
Categories: General Medicine News, GastroenterologyTweet-
“The Potential Role of Hyperbaric Oxygen Therapy in Patients With Inflammatory Bowel Disease” with Parambir S. Dulai, MD https://t.co/RyhhfES9hz #IBD @PDulaiMD @NMGastro @NorthwesternMed
-
-
Mashup Score: 1Overview of Lean MASH and MASLD – Gastroenterology & Hepatology - 1 month(s) ago
Vincent Wong, MD Mok Hing Yiu Professor of Medicine Department of Medicine and Therapeutics Faculty of Medicine The Chinese University of Hong Kong Hong Kong, China G & H How should lean metabolic dysfunction-associated steatohepatitis be defined? VW By definition, if someone is labeled as having lean metabolic dysfunction-associated steatohepatitis (MASH), 2 criteria should be met. First of all, the patient should be lean. According to the World Health Organization (WHO), a patient with a body mass index
Categories: General Medicine News, GastroenterologyTweet-
“Overview of Lean MASH and MASLD” with Vincent Wong, MD https://t.co/nNz5k3EUU0 #MASH
-
-
Mashup Score: 0Highlights From the Recent World Health Organization Guidelines for Hepatitis B Virus Infection – Gastroenterology & Hepatology - 1 month(s) ago
Douglas T. Dieterich, MD Director, Institute for Liver Medicine Mount Sinai Health System Professor of Medicine Icahn School of Medicine at Mount Sinai New York, New York G & H How much progress has been made, particularly in the United States, toward achieving the World Health Organization goal of global hepatitis B elimination by 2030? DD Neither the United States nor the world is doing well at eliminating hepatitis B virus (HBV) infection. Globally, it is estimated that at least 246 million people are
Categories: General Medicine News, GastroenterologyTweet-
“Highlights From the Recent World Health Organization Guidelines for Hepatitis B Virus Infection” with Douglas T. Dieterich, MD https://t.co/2bDdG60gb7 #hepatitisb @icahnmountsinai
-
“Hepatocellular Carcinoma Surveillance Following Hepatitis C Virus Cure” with Paul Y. Kwo, MD https://t.co/9J4KsmvRNG @PaulYKwo @StanfordMed #hepatitisc #HCC